Synergistic upregulation of metalloproteinase‐9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF‐κB
- 11 September 1998
- journal article
- Published by Wiley in FEBS Letters
- Vol. 435 (1) , 29-34
- https://doi.org/10.1016/s0014-5793(98)01034-5
Abstract
Matrix metalloproteinase (MMPs) enzymes are implicated in matrix remodelling during proliferative inflammatory processes including wound healing. We report here synergistic upregulation of MMP‐9 protein and mRNA by platelet‐derived growth factor (PDGF) or basic fibroblast growth factor (bFGF) in combination with interleukin‐1α (IL‐1α) or tumour necrosis factor‐α (TNF‐α) in primary rabbit and human dermal fibroblasts. The synergistic interaction between growth factors and cytokines implies that basement membrane remodelling is maximal physiologically when both are present together. The signalling pathways mediating this synergistic regulation are not understood, although analysis of the MMP‐9 promoter has identified an essential proximal AP‐1 element and an upstream nuclear factor kappa‐B (NF‐κB) site. Using electromobility shift assays, binding to the AP‐1 site was only slightly increased by growth factors and cytokines. NF‐κB binding was rapidly induced by IL‐1α or TNF‐α but was neither induced nor potentiated by bFGF or PDGF. Neither AP‐1 nor NF‐κB was therefore sufficient on its own for synergistic regulation. Using a recently developed adenovirus that overexpresses the inhibitory subunit, IκBα, we demonstrated an absolute requirement for NF‐κB in upregulation of MMP‐9. Activation of NF‐κB binding by inflammatory cytokines was therefore necessary but not sufficient for synergistic upregulation of MMP‐9.Keywords
This publication has 22 references indexed in Scilit:
- The AP-1 site and MMP gene regulation: What is all the fuss about?Matrix Biology, 1997
- Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoterCancer Letters, 1996
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996
- Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B.The Journal of Experimental Medicine, 1996
- Interleukin-1 and Transforming Growth Factor-α: Synergistic Stimulation of Metalloproteinases, PGE2, and Proliferation in Human FibroblastsExperimental Cell Research, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Differential regulation of metalloprotease steady‐state mRNA levels by IL‐1 and FGF in rabbit articular chondrocytesFEBS Letters, 1992
- Induction of interleukin‐1 receptors on chondrocytes by fibroblast growth factor: A possible mechanism for modulation of interleukin‐1 activityJournal of Cellular Physiology, 1989
- Interleukin-1 Mitogenic Activity for Fibroblasts and Smooth Muscle Cells Is Due to PDGF-AAScience, 1989
- Secretory products of macrophages.Journal of Clinical Investigation, 1987